As the Director of Sales - Region Head Americas for Epigenetics at Active Motif, Chris Balagtas plays a pivotal role in bridging the gap between cutting-edge biotechnology solutions and the life science community. With a deep-seated passion for advancing research capabilities, Chris is dedicated to...
As the Director of Sales - Region Head Americas for Epigenetics at Active Motif, Chris Balagtas plays a pivotal role in bridging the gap between cutting-edge biotechnology solutions and the life science community. With a deep-seated passion for advancing research capabilities, Chris is dedicated to empowering scientists and researchers in their quest for discovery and target validation. His expertise spans a diverse array of specialized fields, including DNA and RNA analysis, epigenetics, next-generation sequencing (NGS), proteomic mass spectrometry, single-cell technologies, and bioinformatics. This extensive knowledge base allows him to tailor solutions that meet the unique needs of clients, ensuring that every result counts in their research endeavors.
Leading a dynamic team of seven sales professionals, Chris fosters a high-energy environment that emphasizes collaboration and innovation. Together, they are committed to promoting the routine use of epigenetic tests and therapies, which hold the potential to revolutionize medicine. Under his guidance, the team excels in technical sales, leveraging their understanding of complex scientific concepts to provide exceptional customer service and support. Chris’s strategic vision and leadership not only drive sales growth but also enhance client relationships, positioning Active Motif as a trusted partner in the life sciences sector.
With a focus on continuous improvement and a results-oriented mindset, Chris Balagtas is not just selling products; he is championing a future where advanced epigenetic solutions transform research and clinical applications, ultimately contributing to groundbreaking advancements in healthcare. His commitment to excellence and innovation makes him a key figure in the biotechnology landscape, dedicated to making a meaningful impact in the lives of researchers and patients alike.
